Handelsbanken Fonder Ab Zai Lab LTD Transaction History

Handelsbanken Fonder Ab

  • $25.3 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
SELL
$22.97 - $30.58 $594,923 - $792,022
-25,900 Reduced 27.38%
68,685 $1.88 Million
Q2 2023

Aug 02, 2023
SELL
$25.3 - $39.67 $14,421 - $22,611
-570 Reduced 0.6%
94,585 $2.62 Million
Q1 2023

Apr 28, 2023
BUY
$30.21 - $48.1 $252,736 - $402,404
8,366 Added 9.64%
95,155 $3.17 Million
Q4 2022

Feb 07, 2023
BUY
$22.28 - $38.71 $629,209 - $1.09 Million
28,241 Added 48.24%
86,789 $2.66 Million
Q3 2022

Oct 27, 2022
BUY
$34.2 - $51.69 $176,061 - $266,100
5,148 Added 9.64%
58,548 $2 Million
Q2 2022

Aug 03, 2022
BUY
$23.14 - $49.68 $351,728 - $755,136
15,200 Added 39.79%
53,400 $1.85 Million
Q1 2022

May 11, 2022
BUY
$27.77 - $64.4 $61,094 - $141,680
2,200 Added 6.11%
38,200 $1.68 Million
Q4 2021

Feb 08, 2022
BUY
$54.9 - $105.21 $356,850 - $683,865
6,500 Added 22.03%
36,000 $2.26 Million
Q3 2021

Nov 10, 2021
BUY
$105.0 - $178.37 $357,000 - $606,458
3,400 Added 13.03%
29,500 $3.11 Million
Q2 2021

Aug 03, 2021
BUY
$125.11 - $180.0 $225,198 - $324,000
1,800 Added 7.41%
26,100 $4.62 Million
Q1 2021

Apr 29, 2021
SELL
$126.27 - $191.71 $164,151 - $249,223
-1,300 Reduced 5.08%
24,300 $3.24 Million
Q4 2020

Feb 11, 2021
BUY
$81.94 - $135.34 $2.1 Million - $3.46 Million
25,600 New
25,600 $3.47 Million

Others Institutions Holding ZLAB

# of Institutions
121
Shares Held
46.7M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.52B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email